Skip to main content
Premium Trial:

Request an Annual Quote

Money for Microfluidics

Premium

The Ontario Institute for Cancer Research is investing in a microfluidics technology developed at the University of Toronto in the hope that it will aid in the commercialization of new cancer therapies. The high-throughput digital microfluidics screening technology called a Smart Well Plate is a small device the size of a hand, has no moving parts, and may allow for less expensive screening of chemical libraries in the drug discovery process, says OICR's Chief Commercialization Officer Frank Stonebanks. Digital microfluidics simplifies the screening process, requiring a much smaller amount of cells and reagents to do the testing, OICR adds.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.